Literature DB >> 14634855

Acute phase response in patients undergoing lumbar spinal surgery: modulation by perioperative treatment with naproxen and famotidine.

M Muñoz1, J J García-Vallejo, J M Sempere, R Romero, E Olalla, C Sebastián.   

Abstract

In orthopaedic surgery, perioperative administration of non-steroidal anti-inflammatory drugs has been shown to reduce postoperative pain and analgesic consumption. In addition, preoperative administration of ibuprofen has proved to reduce interleukin-6 (IL-6) release, while that of ranitidine reduced postoperative IL-6-induced C-reactive protein synthesis in patients undergoing abdominal surgery. However, it has not been established whether the preoperative administration of both types of drugs may reduced the postoperative inflammatory reaction after instrumented spinal surgery. Accordingly, our objective was to investigate the effects of preoperative treatment with naproxen plus famotidine on the postoperative systemic inflammatory reaction in patients undergoing instrumented lumbar spinal surgery. Forty consecutive patients scheduled for elective instrumented spinal fusion were alternately assigned to receive either naproxen (500 mg/day, p.o.) plus famotidine (40 mg/day, p.o.) for 7 days before operation, or no adjuvant treatment. Haematological parameters, acute phase proteins, complement fractions, immunoglobulins and cytokines were determined 7 days and immediately before surgery, and on days 0, 1, 2 and 7 after surgery. Haematological parameters, clinical data, duration of surgery, blood loss, perioperative blood transfusion and postoperative complications were similar in the two groups, although pretreated patients showed lower increases in body temperature and required less analgesic medication. Compared with preoperative levels, IL-6 levels were significantly increased postoperatively in all patients with no differences between groups. C-reactive protein, alpha(1)-acid-glycoprotein and haptoglobin levels were also significantly increased postoperatively in all patients; however, they were significantly lower in pretreated patients. In conclusion, perioperative treatment with naproxen plus famotidine was well tolerated and reduced the acute phase response after instrumented spinal surgery. However, further research is needed to determine the best dose and timing of preoperative treatment administration, and to correlate these changes with long-term clinical results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634855      PMCID: PMC3468054          DOI: 10.1007/s00586-003-0641-9

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  34 in total

Review 1.  Biologic control of injury and inflammation: much more than too little or too late.

Authors:  X Guirao; S F Lowry
Journal:  World J Surg       Date:  1996-05       Impact factor: 3.352

2.  Immunological suppression after surgery in scoliosis patients.

Authors:  N Suzuki; O Kaneko; T Nakayama; Y Fukuiya; S Kuge; Y Fujimura
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

Review 3.  Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein.

Authors:  S D Shiyan; N V Bovin
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Serum haptoglobin suppresses T-lymphocyte functions following burns.

Authors:  F Wang; W Huang; A Li
Journal:  Chin Med Sci J       Date:  1996-09

5.  Cytokine and hormonal changes after cholecystectomy. Effect of ibuprofen pretreatment.

Authors:  C Chambrier; D Chassard; J Bienvenu; F Saudin; B Paturel; C Garrigue; Y Barbier; P Boulétreau
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

6.  Elective orthopedic surgery, a model for the study of cytokine activation and regulation.

Authors:  M van Deuren; T B Twickler; M C de Waal Malefyt; H Van Beem; J van der Ven-Jongekrijg; C M Verschueren; J W van der Meer
Journal:  Cytokine       Date:  1998-11       Impact factor: 3.861

7.  Mast cells mediate acute inflammatory responses to implanted biomaterials.

Authors:  L Tang; T A Jennings; J W Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

8.  Ranitidine reduces postoperative interleukin-6 induced C-reactive protein synthesis.

Authors:  L A Rasmussen; H J Nielsen; S Sørensen; C Sørensen; R Rasmussen; S Sørensen; F Moesgaard; J Larsen
Journal:  J Am Coll Surg       Date:  1995-08       Impact factor: 6.113

9.  Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma.

Authors:  D Decker; M Schondorf; F Bidlingmaier; A Hirner; A A von Ruecker
Journal:  Surgery       Date:  1996-03       Impact factor: 3.982

Review 10.  C-reactive protein in orthopedics.

Authors:  C Foglar; R W Lindsey
Journal:  Orthopedics       Date:  1998-06       Impact factor: 1.390

View more
  4 in total

Review 1.  An update on iron physiology.

Authors:  Manuel Muñoz; Isabel Villar; José Antonio García-Erce
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

2.  Evaluation of inflammatory response in patients undergoing surgical treatment for early and delayed femoral fractures.

Authors:  Mehdi Moghtadaei; Babak Otoukesh; Hamidreza Pazoki-Toroudi; Bahram Boddouhi; Ali Yeganeh
Journal:  Arch Med Sci       Date:  2016-10-17       Impact factor: 3.318

3.  Effect of continuous intra-incisional bupivacaine on postoperative pain in non-traumatic spinal fixation surgeries: a randomized controlled trial.

Authors:  Sanaz Jowkar; Arash Farbood; Afshin Amini; Saman Asadi; Babak Pourabbas Tahvildari; Keyvan Eghbal; Naeimehossadat Asmarian; Vahid Parvin; Afshin Zare
Journal:  Braz J Anesthesiol       Date:  2021-12-29

4.  Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.

Authors:  Richard E Kast; Nicolas Skuli; Georg Karpel-Massler; Guido Frosina; Timothy Ryken; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2017-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.